CompletedEUCTR 2004-000589-11
Official study titleProtocol F1D-MC-HGKR. Olanzapine Plus Carbamazepine Versus Carbamazepine Alone in the Treatment of Manic or Mixed Episodes Associated with Bipolar I Disorder
Original registry wording; source language not specified.
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In HungaryBipolarityHistorical research record
- Countries
- Hungary
- Sponsor
- ELI LILLY and COMPANY
Not recruitingEUCTR 2009-016041-25
Official study titleA Long-Term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Original registry wording; source language not specified.
This study isn't currently recruiting.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In GermanyBipolarityHistorical research record
- Countries
- Germany, Hungary, Spain
- Sponsor
- Forest Research Institute, Inc.
Not recruitingEUCTR 2011-004789-14
Official study titleA Multicenter, Open-Label, Flexible-Dose Extension Study of Lurasidone Adjunctive to Lithium or Divalproex in Subjects with Bipolar I Disorder
Original registry wording; source language not specified.
This study isn't currently recruiting.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BulgariaBipolarityHistorical research record
- Countries
- Bulgaria, Croatia, Czechia, + 3 others
- Sponsor
- Sunovion Pharmaceuticals Inc.
Not recruitingEUCTR 2012-001935-30
Official study titleA Prospective, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Safety and Efficacy Study of Oral ELND005 as an Adjunctive Maintenance Treatment in Patients with Bipolar I Disorder
Original registry wording; source language not specified.
This study isn't currently recruiting.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BulgariaBipolarityHistorical research record
- Countries
- Bulgaria, Czechia, Lithuania, + 1 other
- Sponsor
- Elan Pharma International Ltd
CompletedNCT00402324
Official study titleA Double-Blind Placebo Controlled Trial of Divalproex and Olanzapine in Bipolar I Disorder, Mixed Episode
This study has finished and is no longer accepting participants.
In HialeahBipolarityMedication studyAges 18–60
- Countries
- United States
- Sponsor
- Eli Lilly and Company
TerminatedNCT00907985
Official study titleDouble Blind, Double-dummy, Randomised, Placebo Controlled Study to Evaluate the Effect of Single Doses of Drug A (Lamotrigine) and Drug B (Vofopitant) Alone and in Combination on Resting Motor Threshold in Healthy Subjects
This study ended early.
In GöttingenBipolarityMedication studyAges 18–65
- Countries
- Germany
- Sponsor
- GlaxoSmithKline
CompletedNCT00466661
Official study titleA Double-Blind, Randomized, Placebo-Controlled Trial of Acamprosate in Alcohol-Dependent Individuals With Comorbid Bipolar Disorder
This study has finished and is no longer accepting participants.
In CharlestonBipolarityMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Medical University of South Carolina
CompletedNCT00931723
Official study titleAn International, Multicenter, Double-blind, Randomized, Placebo-controlled, Phase IV Study of the Safety and Efficacy of Lithium Versus Placebo as an Add on to SEROQUEL XR (Quetiapine Fumarate) in Adult Patients With Acute Mania
This study has finished and is no longer accepting participants.
Multiple locations, including Montignies-sur-SambreBipolarityMedication studyAges 18–65
- Countries
- Belgium, Bulgaria, Germany, + 6 others
- Sponsor
- AstraZeneca
CompletedNCT04130529
Official study titleBetter Sleep in Psychiatric Care - Bipolar. A Randomized Naturalistic Study of a Psychological Group Treatment for Sleep Problems in Psychiatric Patients With Bipolar Disorder
This study has finished and is no longer accepting participants.
In StockholmBipolarityBehavioural studyAges 18+
- Countries
- Sweden
- Sponsor
- Karolinska Institutet
CompletedNCT00067938
Official study titleLamictal for Use in Treatment of Bipolar Disorder In Adults. A Practical Clinical Assessment of Tolerability and Clinical Effectiveness.
This study has finished and is no longer accepting participants.
Multiple locations, including AlbertvilleBipolarityMedication studyAges 18+
- Countries
- United States
- Sponsor
- GlaxoSmithKline
CompletedNCT05480124
Official study titleEnhancing Neural Synchrony and Affective Cognitive Control in Bipolar Disorder Using Personalized Transcranial Alternating Current Stimulation (tACS)
This study has finished and is no longer accepting participants.
In Ann ArborBipolarityDevice studyAges 18–55
- Countries
- United States
- Sponsor
- University of Michigan
